2024 - Leveraging Functional Service Providers for Enhanced Efficiency in Drug Development

Discover an informative webinar to learn how functional service providers (FSPs) are transforming the clinical research landscape by providing specialized skills, adaptable resources and cost-efficient solutions.
As drug development costs continue to escalate, sponsors need to find less expensive approaches to develop their assets. One way to be more cost-efficient is to outsource some areas of drug development. FSPs have reshaped clinical research by offering specialized skills and adaptable resources.
As trials become more complex, many biotech and biopharma companies are opting for FSPs over full-service outsourcing. FSPs provide numerous advantages such as globalized strategies, expert domain knowledge and efficient management, thus helping balance quality, innovation and cost.
Sponsors engage FSP models when seeking efficiencies. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service clinical research organization (CRO) offerings. FSPs deliver capabilities across a broad base, including subject matter experts in the functional areas, which helps accelerate drug development and decrease overall costs.
A sponsor should feel a true partnership with an adaptable provider willing to help achieve high-quality, cost-effective results as clinical trials are becoming complex and require specific expertise.
Register for this webinar today to learn about the strategic advantages, including expert domain knowledge, global strategies and operational flexibility, for biotech and biopharma companies in engaging functional service providers for drug development.
Keywords: Clinical Trials, Drug Development, Drug Pricing, Clinical Research, Drug Safety, CRO, Drug Manufacturing, Functional Service Provider, FSP, Commercialization/HEOR/Market Access